Room temperature version of coagulation factor
Novo Nordisk UK has announced that NovoSeven – its recombinant activated factor VII product available for the treatment of bleeding episodes in people with haemophilia with inhibitors – is now available as a room temperature stable formulation from today onwards. This replaces the previous formulation, which required refrigeration.
Continue reading - simply register below
It only takes two minutes to do and you'll immediately have access to our news and opinion articles and you'll be able to sign up for our newsletters.